On its third quarter of 2026 earnings call, held on Nov. 5, 2026, Organogenesis (ORGO -3.46%) reported sequential revenue growth despite severe policy-driven industry contraction. Regulatory changes to Medicare reimbursement drastically shrank the broader market, making profitability dependent on commercial execution and scientific evidence. Three things management said stand out.1. Shifting Reimbursement Policies Are Clearing Out CompetitorsFederal policy changes disrupted the skin substitute market, but l ...

Organogenesis (NasdaqCM:ORGO) Q3 2026 Earnings call November 05, 2026 05:00 PM ET Company ParticipantsGary Gillheeney Sr. - President, CEO, and Chair of the BoardDave Francisco - CFOConference Call ParticipantsRyan Zimmerman - AnalystRavi Misra - AnalystOperatorWelcome, ladies and gentlemen, to the third quarter 2026 earnings conference call for Organogenesis Holdings Inc. At this time, all participants have been placed in listen-only mode. Please note that this conference call is being recorded and that th ...

Organogenesis (NasdaqCM:ORGO) Q3 2026 Earnings call November 05, 2026 05:00 PM ET Speaker0Welcome, ladies and gentlemen, to the third quarter 2026 earnings conference call for Organogenesis Holdings Inc. At this time, all participants have been placed in listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looki ...

CANTON, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacture, and sale of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Results Summary: Net revenue of $45.5 million for the third quarter of 2026, a d ...